Home / News / India News / Article /
Serum Institute asks govt to speak with EU for inclusion
Updated On: 29 June, 2021 07:25 AM IST | New Delhi | Agencies
Co says exclusion will affect students, business travellers, economy; Europe allows Oxford-AstraZeneca vaccine, but not Covishield which is its locally manufactured version

Beneficaries wait in a queue to receive Covid-19 vaccine dose, at a district hospital in Noida, on Monday. Pic/PTI
Serum Institute of India (SII) has requested the Centre to take up the matter of inclusion of Covishield vaccine in the EU Covid-19 Vaccination Passport with the European Union and other countries, citing this will affect students and business travellers and cause severe disruptions to the Indian and global economy.
Only four vaccines — Comirnaty of Pfizer/BioNTech, Moderna, Vaxzervria by AstraZeneca-Oxford and Johnson & Johnson’s Janssen — have been approved by the European Medicines Agency (EMA) and only those vaccinated by these vaccines will be given vaccination passports and will be allowed to travel within the EU during the pandemic.
How do you like the new new mid-day.com experience? Share your feedback and help us improve.

